Decibel Announced Launch Into New Product Category, Infused Pre-Rolls

4.2 min readPublished On: November 11th, 2021By

CALGARY, AB – Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF), a cannabis producer, announced the first shipment of its newest product line, infused pre-rolls, under its General Admission brand. In the past three months, the General Admission brand has become the second largest vape brand in Canada by retail sales1. These products will be available for licensed retailers in Alberta first, with shipments to BC and Saskatchewan in November and Ontario in January.

Decibel plans to launch three additional series & types of infused pre-rolls over the next three months under both the General Admission and Qwest brands in the largest markets in Canada.

“We are incredibly excited to launch the first series of our infused pre-rolls under the General Admission brand” said Warren Matzelle, Decibel Sr. Vice President of Innovation & Retail. “This brand extension of the 2nd ranked vape brand in Canada, brings together the potency and flavours consumers love in our General Admission vapes in a convenient and innovative pre-roll format.”

Terpene Infused, Kief Coated Pre-Rolls

The first line of Decibel’s infused pre-rolls is the General Admission terpene infused, kief coated pre-rolls in 1x1g and 3×0.5g size formats. The terpene infused pre-roll line comes in 3 flavours, mirroring the most popular General Admission vapes:

  • General Admission Tropic GSC in two SKUs 1x1g & 3×0.5g
  • General Admission Berry G33 in two SKUs 1x1g and 3×0.5g
  • General Admission Strawnana in one SKU 3×0.5g

Infused Pre-Roll Category

The infused pre-roll category has shown significant growth in established cannabis markets in the US and Decibel anticipates the category to accelerate the growth of the concentrate and pre-roll categories in Canada.

Infused pre-roll category has grown to 44% of all pre-roll sales in California2
Pre-rolls in Canada have grown to 24% of the overall Canadian cannabis market1

1 HiFyre Retail Analytics, Licensed Producer Sales, Category Sales over Time in Canada; August 1 – October 31, 2021

2 Headset, Category Details, Pre-Roll, Category Sales over Time in California; November 1, 2020 – October 31, 2021

Cautionary Statements

Forward Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

In this news release, forward-looking statements relate to, among other things, the Company’s business plans and strategies, anticipated product launches, including the timing, location and availability of the same and the Company’s ability to grow Qwest, Qwest Reserve and Blendcraft brands into new and innovative product formats, variations and its other business plans and expectations. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: risks relating to delays, regulatory changes and impacts, capital requirements, construction impacts, displacement requirements and unforeseen requirements resulting from the COVID-19 pandemic, the ability to obtain and maintain licences to retail cannabis products; review of the Company’s production facilities by Health Canada and maintenance of licences (including any amendments thereto) from Health Canada in respect thereof; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the labour market generally and the ability to access, hire and retain employees; general business, economic, competitive, political and social uncertainties; the satisfaction of conditions precedent under the Company’s credit facilities; timing and completion of construction and expansion of the Company’s production facilities and retail locations; and the delay or failure to receive board, regulatory or other approvals, including any approvals of the TSX Venture Exchange, as applicable. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release.

These forward-looking statements are made as of the date of this press release and, except as required by law, the Company assumes no obligation to update the forward-looking statements or beliefs, opinions, projections, or other factors, should they change.

(This information is primarily sourced from Decibel Cannabis Company Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!